Skip to content
Saturday, November 14, 2026
BlogProMedia UK

Zimbabwe Declines ‘One-Sided’ American Healthcare Assistance Agreement Due to Information Fears

Medical aid image
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over the United States' demand for confidential information.

The decision became public following a official document from December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesman later explained that the US was demanding access to genetic material for scientific study and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for further dialogue to reach a agreement suitable to both sides so the nation's vital HIV programme can proceed.

Wider Background

This rejection follows a comparable situation in Kenya, where a high court suspended a similar deal with the US after legal challenges were raised about the security of citizens' health data.

After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

According to statements, Sixteen African countries have so far signed these new agreements, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"Our nation was requested to share its genetic material and health information for a long time, with no equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.

"Put simply, our country would provide the basic resources for medical research with no certainty that the end products would be available to our population should a future disease outbreak arise."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously established through the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with future pandemics.

"This system is designed to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued dialogue with our US partners on how future collaboration could be arranged in a manner that respects the sovereignty and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but suggested that talks should continue given that much of the country's HIV programmes were funded by external financing.

"If technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," the group commented.

This impasse underscores the ongoing challenges between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.

About the author

Jean Clark

A digital strategist with over a decade of experience in content marketing and SEO, specializing in helping UK businesses thrive online.

BlogProMedia UK

Type to search articles.